Search

Your search keyword '"Colletta, C."' showing total 2 results
Start Over Author "Colletta, C." Journal journal of viral hepatitis
2 results on '"Colletta, C."'

1. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Author

Bruno, S., Bollani, S., Zignego, A. L., Pascasio, J. M., Magni, C., Ciancio, A., Caremani, M., Mangia, A., Marenco, S., Piovesan, S., Chemello, L., Babudieri, S., Moretti, A., Gea, F., Colletta, C., Perez-Alvarez, R., Forns, X., Larrubia, J. R., Arenas, J., Crespo, J., Calvaruso, V., Silberstein, Ceccherini F., Maisonneuve, P., Craxì, A., and Calleja, J. L.

Published
2015
Full Text
View/download PDF

2. Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon

Author

Toccaceli, F, Laghi, V, Capurso, L, Koch, M, Sereno, S, Scuderi, M, Stellini, R, Cristini, G, Zammataro, M, Russello, M, Pizzigallo, E, Vecchiet, J, Guaglianone, L, Vigna, L, Frugiuele, Pl, Milani, S, Pignalosa, P, De Conca, V, Mesiti, S, Castellacci, R, Mignani, El, Artioli, Sl, De Luca Andrioli, E, Maci, Am, Ascione, A, De Luca, M, Persico, M, Palmentieri, B, Esposito, P, Iuliano, D, Tarantino, G, Conca, P, Scolastico, C, Stanzione, M, Colletta, C, Montalto, G, Vuturo, O, Tripi, S, Alessandri, A, Sabatella, C, De Stefano, G, Ceglia, T, Fornaciari, G, Castagnetti, E, Barlattani, A, Veglio, V, Bonasso, M, Starnini, G, Scotto, G, Toccaceli, Fabrizio, Laghi, V., Capurso, Mauro, Koch, M., Sereno, S., Scuderi, M., Stellini, R., Cristini, G., Zammataro, M., Russello, M., Pizzigallo, E., Vecchiet, J., Guaglianone, L., Vigna, L., Frugiuele, P. L., Milani, S., Pignalosa, P., De Conca, V., Mesiti, S., Castellacci, R., Mignani, E., Artioli, S., De Luca Andrioli, E. P., Maci, A. M., Ascione, A., De Luca, M., Persico, M., Palmentieri, B., Esposito, P., Iuliano, D., Tarantino, Giovanni, Conca, P., Scolastico, C., Stanzione, M., Colletta, C., Montalto, G., Vuturo, O., Tripi, S., Alessandri, A., Sabatella, C., De Stefano, G., Ceglia, T., Fornaciari, G., Castagnetti, E., Barlattani, A., Veglio, V., Bonasso, M., Starnini, G., and Scotto, G.

Subjects
Adult, Liver Cirrhosis, Male, medicine.medical_specialty, Pathology, Hepacivirus, Biopsy, Alpha interferon, Infectious Disease, Chronic hepatitis C, Gastroenterology, Statistics, Nonparametric, Fibrosis, Recurrence, Virology, Internal medicine, medicine, Humans, Multicenter Studies as Topic, Aged, Retrospective Studies, Hepatology, medicine.diagnostic_test, biology, business.industry, Interferon-alpha, Retrospective cohort study, Alanine Transaminase, Hepatitis C, Liver biopsy, Hepatitis C, Chronic, Middle Aged, biology.organism_classification, medicine.disease, Infectious Diseases, Alanine transaminase, HCV, biology.protein, Interferon, RNA, Viral, Female, business, chronic hepatitis c, hcv, interferon, liver biopsy
Abstract

A retrospective multicentre survey was conducted to evaluate, in patients with chronic hepatitis C, the long-term liver histological changes induced by interferon (IFN). A total of 112 patients (mean age 46.4 years) were studied. All patients had received a 6-12-month IFN-alpha course (6-18 MU/week) and had successively undergone clinical, biochemical and virological follow-up for at least 36 months (range: 36-76). In each patient, two liver biopsies had been performed: 1-6 months before treatment and, 12-76 months after its completion. In 87 patients with biochemical and virological sustained response persisting for 12 months after therapy, post-treatment liver necroinflammation and fibrosis mean(+/-SD) scores (Knodell index) were significantly lower than pretreatment scores (2.9 +/- 2.2 vs 6.8 +/- 2.9 and 0.8 +/- 1.0 vs 1.2 +/- 1.1, respectively; P0.01). In 25 patients who relapsed within 1 year, necroinflammation and fibrosis post-treatment mean scores were similar to pretreatment scores (7.4 +/- 3.2 vs 6.9 +/- 3.1 and 1.8 +/- 1.3 vs 1.6 +/- 1.2, respectively; P0.05). On an individual basis, necroinflammation decreased in 87% of sustained responders but only in 36% of relapsers (P0.001), whereas fibrosis decreased in 44% of sustained responders but only in 14% of relapsers (P0.001). In sustained responders with biopsies performed 12-23 months (n=34), 24-35 months (n=26) or more than 36 months (n=27) after treatment, a progressive decrease of mean necroinflammatory score was observed (-2.6 +/- 2.1, -4.1 +/- 3.4 and -5.2 +/- 3.7 points, respectively; P0.01). A similar pattern was observed in fibrosis score (-0.3 +/- 0.6, -0.3 +/- 0.7 and -0.7 +/- 0.9 points, respectively; P0.05). Hence, among chronic hepatitis C patients treated with IFN, those with a 12-month sustained response, unlike those who relapse, have a long-term progressive reduction and, in some cases, a complete regression of liver histological damage.

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results